Skip to main content

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

01 Nov 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2023, as compared to corresponding quarter of last year.Profit after Tax for the quarter ended September 2023 saw a decline of -62.85% from Rs. 19.41 millions to Rs. 7.21  millions.A decline of 7.21 millions was observed in the OP in the quarter ended September 2023 from 19.41 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 7.53 -15.37 -148.99 8.28 21.62 -61.70
Other Income 7.57 20.50 -63.07 7.57 20.50 -63.07 0.00 0.07 0.00
PBIDT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 149.67 -22.84 -755.38 55.07 -0.37 -14984.46
Peers
Company Name CMP
Redington 349.60
Adani Enterprises 2682.00
Amrapali Industries 32.78
Maxgrow India 174.80
Rashi Peripheral 689.15
View more..